Albumin Level Monitoring Guidelines

Patient-Specific Monitoring Recommendations

The American Journal of Kidney Diseases recommends serum albumin measurement at least every 4 months in patients on peritoneal dialysis, as a stable or rising albumin value is desirable, and low serum albumin is a strong predictor of mortality and morbidity in these patients 1
The American Diabetes Association recommends checking urinary albumin and eGFR at least annually in patients with type 1 diabetes (duration ≥5 years) and all patients with type 2 diabetes, and 1-4 times per year in patients with established chronic kidney disease (CKD) depending on CKD stage 2, 3, 4
The American Diabetes Association recommends monitoring frequency based on albuminuria and GFR categories, with normal to mildly increased albuminuria and normal GFR requiring annual monitoring, moderately increased albuminuria requiring 1-2 times per year monitoring, and severely increased albuminuria requiring 3-4 times per year monitoring 2, 3, 5
The American Diabetes Association recommends beginning albumin-to-creatinine ratio testing at puberty or ≥11 years old (whichever comes first) and after 3-5 years of diabetes duration in children with type 1 diabetes, and at diagnosis in children with type 2 diabetes, with annual monitoring if normal and repeat testing with confirmation in two of three samples over 6 months if abnormal 6

Increase monitoring frequency in patients with declining albumin levels, active catabolic illness, starting new treatments that may affect albumin levels, or worsening clinical status, as recommended by the American Journal of Kidney Diseases and the American Diabetes Association 1, 5, 7

The American Journal of Kidney Diseases recommends using local laboratory reference ranges for normal serum albumin concentrations and considering both absolute values and trends over time when interpreting results 1
The American Diabetes Association recommends confirming abnormal urinary albumin results with repeat testing due to variability in excretion, and using specific tests for low concentrations of albumin in patients with diabetes 4, 5